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Abstract
Background: In order to close existing information gaps on diabetes-related health perceptions, diabetes knowledge,
and information-seeking behaviors among adults in Germany, a representative population-based survey targeting the
German-speaking population 18 years and older with and without diabetes was conducted. The aim of the present
work was to analyze the psychometric properties of the multi-item scales, applied in the survey in order to provide
guidance for decisions on the use of these measurements for future research.
Methods: Based on data from participants who completed the final survey (N = 1479 with known diabetes; N = 2327
without known diabetes) reliability and unidimensionality of multi-item scales were tested using Cronbach’s Alpha and
confirmatory factor analysis (CFA).
Results: Psychometric properties and model fit varied across scales. Cronbach’s alpha values ranged from very good to
unacceptable. Model fit indices suggested evidence of a single underlying factor in some but not all scales. Adequate
reliability and at least mediocre model fit were found for diabetes distress and patient-provider-relationship in people
with diabetes and for perceived level of information in individuals without diabetes. Scales revealing inacceptable
reliability values or not suggesting unidimensionality were e.g. diabetes-related stigmatization in both individuals with
and without diabetes, self-efficacy in individuals with diabetes, and perceived personal control in those without
diabetes.
Conclusion: Based on results of the current study, some of the scales applied in the survey can be recommended for
present and future analyses of the survey data and for future surveys (e.g. diabetes distress, patient-provider-
relationship in people with diabetes). Other scales should be interpreted and used with caution (e.g. depressive
symptoms in people with diabetes) while others should be reformulated, interpreted only as single items, or need
further investigation (e.g. diabetes-related stigmatization in people with and without diabetes). Findings provide
researchers the opportunity to evaluate diabetes-specific scales in population-based studies of adults with and without
diabetes.
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Background
Diabetes mellitus, in particular type 2 diabetes is a
chronic metabolic disease of great Public Health impact
in Germany and worldwide [1, 2]. The disease requires
lifelong treatment and self-management challenging
both the affected individuals and the society [3].
Extensive health actions are required on a national level
to halt the rise in diabetes and its related consequences
such as complications, comorbidities and premature mor-
tality [4, 5]. Diabetes monitoring with population-based
surveys on a national level is important to inform national
diabetes policies and public health strategies focusing on
the prevention of diabetes and related secondary health
problems [4]. Previous research has shown that there is
growing evidence on the impact of psychosocial and
health care factors on diabetes-self management among
adults with diabetes [5–7]. Likewise, in people without
diabetes, psychosocial factors and health care-related fac-
tors, such as physician counselling or participation in dia-
betes prevention programs appear to be associated with
diabetes preventive behaviors and outcomes, e.g. physical
activity or weight loss [8–13].
There is a lack of population-based surveys, which as-
sess a broad range of diabetes-related concepts that in-
clude not just clinical factors related with diabetes, but
include psychosocial and environmental factors as con-
ceptualized in the International Classification of Function-
ing, Disability and Health (ICF) model [14, 15]. This
model is a valuable framework for structuring our under-
standing of factors associated with a specific condition in-
cluding physiological and psychological functioning,
activities and participation in social life [15], which, in
turn, are related to personal and environmental factors,
representing an individuals’ whole life background. These
factors comprise sociodemographic factors, lifestyle,
habits, past and current experience and other characteris-
tics, but also social structures, health service use, and
social attitudes. A small number of national and inter-
national population-based surveys of individuals with dia-
betes exist that focus on psychosocial and health care
factors that represent the personal and environmental
level [16–23]. However, few surveys so far have focused
on specific diabetes-related information needs and infor-
mation seeking behavior in people with and without diag-
nosed diabetes. (For a review of categories from leading
international diabetes surveys, see Additional file 1).
In order to fill the gap of research on information
needs and information seeking behavior in the context
of psychosocial and environmental factors, the German
“Disease Knowledge and Information Needs – Diabetes
mellitus (2017)” survey was conducted among individ-
uals with and without diabetes. This survey was part of
the national diabetes surveillance system initiative [24].
First results of the survey are presented elsewhere [24].
To gain a broad understanding of potential interrela-
tions between diabetes-related information needs, infor-
mation seeking behavior, disease knowledge and other
relevant health-related concepts a set of other personal
and environmental factors, e.g. health beliefs, risk per-
ceptions, health care utilization or patient-provider-
relationship was included in the survey by drawing on
the ICF model [14, 15], and reviewing existing surveys
and expert discussions. While instruments to tap these
concepts were available from the literature in many al-
beit not all cases, there was a general lack of information
on psychometric properties in population-based settings.
However, such knowledge is the key to inform and sup-
port survey-based in-depth analyses on information
needs and disease knowledge, but also on several of the
concepts measured by multi-item measurements as out-
come variables. Moreover, the results will also be used
to guide future use of these instruments in subsequent
population-based surveys of diabetes-related knowledge
and information needs in Germany and internationally.
Methods
Study design and sample
The survey “Disease knowledge and information needs –
Diabetes mellitus (2017)”, was conducted from August
to December 2017 by the Robert Koch Institute (RKI) in
cooperation with the Office for National Education and
Communication on Diabetes Mellitus of the Federal
Centre for Health Education (BZgA), and the Institute of
Medical Sociology and Rehabilitation Science of the
Charité – Universitätsmedizin Berlin. This project was
funded by the Federal Ministry of Health as part of a lar-
ger project to establish a national diabetes surveillance
system and improved risk communication to the public
[25]. The survey was conducted as a health telephone
survey by applying two standardized interviews, i.e. one
for people without known diabetes and one for people
with self-reported physician diagnosed diabetes. The tar-
get population consisted of German residents who were
at least 18 years old and had sufficient German language
skills to participate in a telephone interview. For the sur-
vey, the intended sample size was N = 1500 for individ-
uals with diabetes and N = 2500 for individuals without
diabetes. The sampling procedure was realized in two
phases using an established dual-frame methodology
considering landline as well as mobile telephone num-
bers in order to obtain representativeness for all poten-
tially reachable private households at a national level. In
a first main survey phase, a sample of the general adult
population was drawn, i.e. including people with and
without diabetes. The Kish Selection Grid method was
applied, i.e. target persons were randomly selected from
multi-person households by a computer-assisted algo-
rithm that was based on the number of adults in a
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household and the sequence of their age. This procedure
ensured the same selection probability for all potential
target persons. Respondents were assigned to one of the
two survey components, i.e. people with and without di-
agnosed diabetes, based on the question “Have you ever
been diagnosed with diabetes by a physician?” (“yes” or
“no”). More detailed information on the sampling pro-
cedure can be found elsewhere [24, 26]. This sampling
phase resulted in complete interviews of 263 individuals
with diabetes and 2327 individuals without diabetes. The
response rate calculated according to the American As-
sociation for Public Opinion Research (AAPOR), i.e. the
proportion of conducted interviews related to all poten-
tially reachable households in Germany, either via land-
line or mobile telephone, was 17.9% [24].
In the second main survey phase a sample of only indi-
viduals with diabetes was drawn by applying a direct
screening procedure, i.e. people were asked whether they
or another person in the household had ever been diag-
nosed with diabetes. In case of more than one person
with diabetes per household, the Kish Selection Grid
method was used as well. A total of 1479 interviews of
people with diabetes was conducted. Overall, the final
survey sample comprised 2327 individuals without
known diabetes and 1479 individuals with a history of
diagnosed diabetes.
Data were collected from August to November of
2017 through computer assisted telephone interviews
(CATI) by the market and social research institute
USUMA GmbH in Berlin, Germany. Interviews were
performed by trained interviewers. Participation in the
survey was voluntary. Individuals received information
on survey procedure and data protection. After that,
they were asked to give verbally informed consent about
their willingness to participate.
Measures
For both survey groups, i.e. one comprising individuals
with known diabetes and the other one comprising indi-
viduals without known diabetes, a customized question-
naire was applied to each group. In order to tap
identified concepts and constructs of the survey, vali-
dated and short German language items and instruments
were chosen, if available. If selected constructs were not
represented adequately by already existing instruments
or only by extensive scales or were not available in Ger-
man language, items were newly developed or adapted
from existing ones by the research team or were trans-
lated from existing English language instruments follow-
ing a forward-backward procedure [27]. Moreover,
survey development included cognitive testing of se-
lected items to test comprehensibility and acceptance.
Following the results of the testing, e.g. a “do not know”
category was added for some items because respondents
noted, they would choose the middle category due to
that missing answer option. Final revisions of items were
conducted following an initial data collection phase
based on difficulties that interviewers noted when con-
ducting the interviews. Final versions of interviews took
on average 32 min to complete for individuals without
diabetes and 43min for individuals with diabetes. A
complete list of concepts, constructs, and instruments as
applied in the main survey can be found elsewhere [24].
The present study focused only on multi-item mea-
sures and scales that were used in the main survey.
Among people with diabetes these were: the optimistic
bias subscale of the Risk Perception Survey-Diabetes
Mellitus (RPS-DM) [28]; the personal control subscale of
the Revised Illness Perception Questionnaire (IPQ-R)
[29, 30]; the self-care ability subscale which was adopted
from the Diabetes Care Profile (DCP) [31]; diabetes-
related stigmatization with two items adopted from the
Diabetes Representative Survey [32] and a new item
based on the Type 2 Diabetes Stigma Assessment Scale
(DSAS-2) [33]; the Problem Areas in Diabetes Scale –
Five-item Short Form (PAID-5) [34]; the Two-item Pa-
tient Health Questionnaire (PHQ-2) [35]; the Patient As-
sessment of Chronic Illness Care-DAWN Short Form
(PACIC-DSF) [36]; and the Information Needs in Dia-
betes Questionnaire (IND) [37]. Among people without
diabetes these were: the optimistic bias subscale of the
Risk Perception Survey-Developing Diabetes (RPS-DD)
[38]; the personal control subscale of the RPS-DD [38];
diabetes-related stigmatization with two items adopted
from the Diabetes Representative Survey and a new item
based on the DSAS-2 [33]; actual diabetes knowledge
with two items adopted from Hoghton et al. [39] and
four new items; and the IND [37] (with only 5 items).
Statistical analyses
Descriptive statistics were reported for sample character-
istics and all scales under study. Descriptive statistics of
items not incorporated into scales are reported else-
where [24]. Psychometric properties were determined
for the scales. All analyses were performed based on data
weighted with sample weights in order to achieve repre-
sentativeness at the national level as described in detail
previously [24]. Individuals who reported a diagnosis of
diabetes by a physician at some point previously in life,
but no presence of diabetes within the last 12 months
and no current medication as well as individuals with a
current gestational diabetes were excluded from the ana-
lyses (n = 83).
Means and standard deviations were reported for the
scales. Reliability was indicated using Cronbach’s alpha
coefficient for scales with more than two items. Values
of Cronbach’s alpha lower than .60 were interpreted to
be unacceptable, between .60 and .65 were considered
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undesirable, between .65 and .70 minimally acceptable,
between .70 and .80 respectable, and values between .80
and .90 were considered very good based on suggestions
for research instruments [40]. For scales comprising two
items, the Spearman-Brown coefficient equivalent to the
standardized coefficient alpha was calculated [41]. The
Spearman-Brown coefficient was calculated for the opti-
mistic bias subscale of the RPS-DM [28] and the PHQ-2
[35] in individuals with diabetes, and for the optimistic
bias subscale of the RPS-DD in individuals without dia-
betes. Analyses were done using the statistic software
SPSS (IBM SPSS v.22.0). Additionally, the unidimen-
sional factorial structure of the scales used in the survey
components was tested by applying confirmatory factor
analysis (CFA), since Cronbach’s Alpha is not recom-
mended to examine unidimensionality [42, 43]. There-
fore, the packages “lavaan” and “lavaan.survey” in R
v3.4.3 were used. First, lavaan.survey was utilized to in-
corporate the sampling weights. Then, to test unidimen-
sionality factor scales were modeled as single-factor
models. For parameter estimation, the robust maximum
likelihood estimator “MLM” was chosen to take the
non-normality of the data into account. The model fit
was evaluated by considering an absolute fit index, the
robust root-mean-square error of the approximation
(RMSEA) and an incremental fit index, the robust
comparative-fit-index (CFI) [44] since they belong to the
commonly used fit indices [45–47]. RMSEA values
under .05 [34] or .06 [28] indicate good model fit, ac-
cording to widely used rules of thumb [45, 48, 49]. Ac-
cordingly, values between .05 and .10 [32] or .05 and .10
[34] indicate mediocre model fit while values above .10
indicate poor model fit [34]. For the CFI, rules of thumb
suggest good model fit occurs with values above 0.95
[44, 50] or, preferably, 0.97 [50]. CFA analyses were
done on scales comprising at least four items, as a mini-
mum of four indicators measuring one latent factor is
necessary for a single-factor model to be overidentified
[51]. For scales comprising less than four items only reli-
ability coefficients were calculated as described before.
Missing data from scale variables were examined and
treated separately for the two subgroups of individuals
with and without diabetes. Missing values were less than
5% for most items. Items with more than 5% of the values
missing included both items of the RPS-DM optimistic
bias subscale (8.0 and 11.7%) in individuals with diabetes
as well as one item each of the RPS-DD optimistic bias
subscale (7.2%) and the RPS-DD personal control subscale
(5.6%) in individuals without diabetes. Missing data were
assumed to be missing at random. Missing data were esti-
mated by applying the expectation-maximization algo-
rithm within SPSS, using age and sex as predictors as well
as the weight variable and all scale variables of the respect-
ive subgroup. This method suited the complex data
structure, including filter variables, by using a single data set
when applying missing data treatment, survey weights
analyses for CFA using lavaan.survey, and estimations of
Cronbach’s alpha coefficient. The expectation-maximization
algorithm has shown superiority over case deletion
methods [52].
Results
Study population
In the sample of 1396 individuals with diabetes, the pro-
portion of women and men was comparable (49.9% vs.
50.1%) (Table 1). Participants had a mean age of 65.3
years (SD = 13.8). About one in two was married and
lived with their partner (50.2%). Almost half of the sam-
ple (46.8%) had a low educational level while 13.5% of
the participants were highly educated. In this sample,
79.2% of the participants stated they had type 2 diabetes,
14.0% had type 1 diabetes, and a few reported another
type of diabetes (1.3%), while 5.5% reported they did not
know. Average diabetes duration was 14.7 years (SD =
11.0). More than half of the participants reported to
have none of the complications related to diabetes pre-
sented in the survey (58.4%) whereas 34.7% reported at
least one complication. The mean BMI was 29.4 kg/m2
(SD = 5.5). In the sample of N = 2327 individuals without
diabetes the proportion of women and men was similar
as well (51.7% vs. 48.3%). The mean age was 49.6 years
(SD = 18.6). While 30.7% of the participants had a low
educational level, 26.9% were classified as highly edu-
cated. Participants in this sample had a mean BMI of
25.5 kg/m2 (SD = 4.4).
Scale distributions
Distributions and ranges of scales from both survey
components are summarized in Additional file 2. In in-
dividuals with diabetes, scale means approximated the
theoretical scale mean (i.e., on a 1–2–3-4-5 scale the
theoretical mean would be 3) for: relative risk perception
(i.e., optimistic bias) of getting complications (M = 2.6;
SD = 2.7), patient-provider-relationship in terms of the
patients’ assessment of care (M = 2.5; SD = 1.0), and the
perceived level of information (M = 2.7; SD = 0.6). Scale
means were below the theoretical scale mean for
diabetes-related stigmatization (M = 2.0; SD = 0.8), dia-
betes distress (M = 3.4; SD = 4.3), and depressive symp-
toms (M = 1.2; SD = 1.6). Scale means of perceived
personal control (M = 16.0; SD = 2.8) and self-efficacy
(M = 3.6; SD = 0.4) were higher than the theoretical scale
mean. Additional scale information on diabetes-related
stigmatization is given in Additional file 3: Table S1.
In those without diabetes, the scale mean of perceived
personal control (M = 1.9; SD = 0.5) was below the the-
oretical scale mean. For relative risk perception (i.e., op-
timistic bias) of developing diabetes (M = 2.3; SD = 0.7),
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Table 1 Sample characteristics for individuals of the parallel survey components
People with diabetes (na = 1396) People without diabetes (na = 2327)
Age in years, mean (SD) 65.3 (13.8) 49.6 (18.6)
Sex (% female) 49.9 51.7
Relationship status
Married, living together with partner 50.2 46.2
Married, living apart 2.4 3.0
Single 13.1 32.5
Divorced/separated 10.5 9.1
Widowed/partner died 23.7 8.9
Educational levelb
Low 46.8 30.7
Average/medium 39.6 42.2
High 13.5 26.9
Migration background
No migration background 88.4 80.3
Onesided (one parent was born in another country than Germany) 4.8 4.8
Twosided (Both parents or individual itself plus one parent were
born in another country than Germany)
6.6 14.7
Living area
< 20.000 citizen 43.6 41.5
≥ 20.000 citizen 43.0 47.2
Diabetes type (self-reported)
Type 1 14.0
Type 2 79.2
Others 1.3
Diabetes duration (years), mean (SD) 14.7 (11.0)
Current treatmentc
Glucose-lowering tablets 61.5
Insulin 50.2
Other glucose-lowering medicine being injected 4.9
Diet/healthy nutrition 58.0
Physical activity/sports 52.9
No treatment 0.6
Diabetes related complications
No complication 58.4
One or more of the requested complicationsd 34.7
Other complications than requested 2.4
Comorbiditiese
No comorbidities 57.7
One or more comorbidities 41.1
BMI in kg/m2, mean (SD) 30.2 (6.0) 25.6 (4.6)
Note. Data are given as weighted and are reported in percent if not stated otherwise. Missing values based on unweighted data were ≤ 10% for living area in
individuals with and without diabetes. Missing values were ≤ 5% for all other variables
aSample sizes are reported unweighted
bComparative Analysis of Social Mobility in Industrial Nations (CASMIN) classification was used to report educational level
cMultiple answers were possible
dComplications asked in this survey were kidney disease, eye disease, nervous disease, diabetic foot lesions and amputations
eComorbidities asked in this survey were heart attack, stroke, coronary heart disease, depression diagnosed by a physician/psychotherapist
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diabetes-related stigmatization (M = 2.5; SD = 0.7), actual
diabetes knowledge (M = 2.5; SD = 1.6) and perceived
level of information (M = 2.3; SD = 0.7) scale means were
close to or only slightly below their theoretical scale
means. Additional scale information on diabetes-related
stigmatization and actual diabetes knowledge are given
in Additional file 3: Tables S2 and S3.
Reliability and factorial structure
A complete overview of the psychometric properties of
the survey measures for people with and without diabetes
is given in Additional file 2. For measures applied among
persons with diabetes, scale reliability as assessed by Cron-
bach’s alpha values ranged from .53 for self-efficacy to .90
for perceived level of information. Values for perceived
level of information (α = .90), diabetes distress (α = .88),
patient-provider-relationship in terms of the patients’ as-
sessment of care (α = .85), perceived personal control
(α = .76), and relative risk perception of getting complica-
tions (α = .71) were within the range from respectable to
very good reliability. For self-efficacy, depressive symp-
toms, diabetes-related stigmatization, and health literacy
Cronbach’s alpha values ranged from unacceptable to
minimally acceptable. The lowest value returned for
diabetes-related stigmatization (α = .52).
Using CFA to further test the unidimensional factorial
structure of scales in participants with known diabetes,
RMSEA values ranging from .06 for self-efficacy to .21
for perceived personal control were found. The CFI
value was lowest for perceived level of information
(CFI = .90) and highest for self-efficacy (CFI = .98). The
model test for perceived personal control revealed an
RMSEA = .21 and a CFI = .91, both indicating poor
model fit. The same applies to perceived level of infor-
mation (RMSEA = .11 and CFI = .90). For diabetes dis-
tress, the RMSEA was .13, which indicates poor fit,
whereas the CFI was .97 which indicates good fit. The
model fit indexes for patient-provider-relationship in
terms of the patients’ assessment of care (RMSEA = .07
and CFI = .96) and self-efficacy (RMSEA = .06 and CFI =
.98) indicated mediocre to good fit.
For individuals without diabetes, values of scale reliabil-
ity ranged from .31 to .91. Cronbach’s alpha reliability co-
efficients of the relative risk perception of getting diabetes
(α = .65) and perceived level of information (α = .91) can
be described as minimally acceptable and very good, re-
spectively. Perceived personal control, diabetes-related
stigmatization, and actual diabetes knowledge returned
unacceptable to undesirable Cronbach’s alpha coefficients,
with diabetes-related stigmatization having the lowest
value (α = .31).
Applying CFA for the assessment of unidimensionalty
in the sample of individuals without diabetes, the fit
index RMSEA ranged from .07 for perceived level of
information to .19 for perceived personal control. Like-
wise, the CFI ranged from .73 for perceived personal
control to .99 for perceived level of information. For per-
ceived personal control, the resulting RMSEA of .19 and
CFI of .73 indicated poor fit. Regarding actual diabetes
knowledge, an RMSEA of .10 and CFI of .94 similarly in-
dicated poor fit. For perceived level of information, the
RMSEA of .07 indicated mediocre fit while the CFI of
.99 indicated good fit.
In the present study, we tested unidimensional scales.
Although beyond of the scope of the study, examples of
alternative scale structures for specific scales can be
found in Additional file 4: Tables S1 and S2.
Discussion
The present study investigated the psychometric proper-
ties for multiple item measures used in a survey that fo-
cused on disease knowledge and information needs as
well as related factors as conceptualized in the ICF
model [14, 15]. Scales were administered in individuals
with diabetes, in individuals without diabetes, or in both
groups depending on scale content. Based on the evalu-
ation of reliability coefficients and factorial structures,
which were found in this study, we provide recommen-
dations for the use of the investigated multiple item
measures or scales in both people with and without dia-
betes in future national or international population-
based surveys on diabetes prevention and care.
Evaluation of scales by means of reliability in conjunction
with factorial structure
In participants with diabetes, for some scales respectable-
to-very good reliability coefficients but also poor or mixed
justification for a single underlying dimension were found.
This may have been occurred for several reasons. For ex-
ample, for the perceived personal control subscale of the
German IPQ-R whose reliability was largely in line with
the results of the evaluation of the German IPQ-R [30],
poor values of fit indices of the CFA might have been as-
sociated with length of the subscale and associated low
number of degrees of freedom [53, 54].
For the PAID-5, reliability was in line with findings by
McGuire et al. [34], whereas mixed results of model fit
did not fully support the one-factor solution of an ex-
ploratory factor analysis found by McGuire et al. [34] or
the one-factor model found through the application of
CFA in a Korean study [55]. However, different results
may be explained by model modification that was ap-
plied in the Korean study but not in the current study or
by different administration modes of the scale. In the
Korean study, the PAID-5 was administered to partici-
pants in written form whilst in the current study it was
administered verbally over the phone [55]. Thus, the
mode of administration as well as further analyses of
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model fit including model modifications should be ad-
dressed in future research.
For the perceived level of information, lack of evi-
dence for unidimensionality may be explained by the
fact that the primary aim of the IND is to identify infor-
mation gaps in individuals with diabetes and changes in
their information needs over time. Overall, in the
current study the factor-analytical results suggest single
items to be used, instead of a composite score. None-
theless, results indicated unidimensionalty for perceived
level of information in individuals without diabetes,
which was assessed with a reduced number of items of
the IND. Thus, there might be potential to generate a
score that assesses an overall perceived level of infor-
mation on diabetes.
Other scales in people with diabetes showed moder-
ate or good model fit but differed in their reliability.
For diabetes-specific self-efficacy, which was assessed
with the modified self-care ability scale [31], reliability
appeared to be low whereas Fitzgerald et al. [31]
found respectable reliability in a US sample. Items
may have been less interrelated in the current study
due to the modification of a single item or translation
processes. However, the low scale reliability should be
taken into account when applying or interpreting this
scale. Another scale, the PACIC-DSF, however, showed
good reliability.
In people without diabetes, in contrast to the per-
ceived level of information, the personal control subscale
and actual diabetes knowledge seemed to perform poorly
in terms of reliability as well as model fit. The personal
control subscale showed a lower Cronbach’s alpha coef-
ficient than the one found for a US sample with an Eng-
lish version and for a Spanish sample with a Spanish
version of the RPS-DD [56]. Moreover, Joiner et al. [57]
found the personal control scale to be unidimensional
only after removing two of the four items, when applying
exploratory principal components analyses. Translation
of the scale into German language or the conception of
items among the German population may have caused
additional heterogeneousness. However, disparity among
items could also indicate that alternative factorial struc-
tures fit the data more adequately and should be further
investigated when applied to the German population.
For actual diabetes knowledge, results suggest that a
single latent factor model representing a single dimen-
sion of diabetes knowledge may not optimally fit the
data. A model taking into account different facets of the
items assessing diabetes knowledge such as knowledge
related to biological mechanisms of diabetes, knowledge
specific to type 2 diabetes, and specific to type 1 diabetes
might be more suitable to fit the data as people might
have knowledge regarding one diabetes type but not the
other. The use of specific knowledge questions (i.e.,
single items) for specific types of diabetes may be
recommended.
Evaluation of scales based on reliability only
Relative risk perception was assessed in people with and
without diabetes, using group-specific optimistic bias
scales. Reliability coefficients found in the current study
were in line with results of a prior study using an Eng-
lish version of the optimistic bias scale in people without
diabetes [38] on the one hand. One the other hand they
were slightly lower or lower than in studies applying an
English or Spanish version in people with diabetes [28]
and without diabetes [57]. For our survey, items of the
optimistic bias subscales have been translated into Ger-
man language. Although the rate of missing data for
items of both optimistic bias scales was acceptable for a
telephone survey, it was higher than in any other items
of scales investigated in this study. Missingness of the
optimistic bias items is in part likely due to the complex-
ity of phrasing and thus missingness response patterns
should carefully be inspected if the optimistic bias sub-
scales will be applied in a future telephone survey.
The PHQ-2 was used to assess depressive symptoms
in individuals with diabetes. In this instrument, one
item represented the lowering of mood and another the
lack of interest. Results of the present study indicated
lower reliability than the results found in a primary care
sample by Löwe et al. [58]. Items seemed to be more
heterogeneous in the sample of individuals with dia-
betes compared to the primary care sample, which in-
cluded individuals who did not necessarily have
diabetes. As Furuya et al. [59] suggested, two-item
questionnaires assessing depressive symptoms could
show different characteristics among different popula-
tions such as in individuals with or without diabetes
and thus should be further investigated. Based on our
findings, we cannot give an unconditional recommen-
dation for the use of the two-item depression scale
among those with diabetes.
For diabetes-related stigmatization in individuals with
and without diabetes unacceptable reliabilities and un-
clear factorial structures, as these could not be tested
due to the insufficient number of items, suggest that
items may not be used to generate a scale score repre-
senting overall stigmatization but may be used as single
item measures. In future studies, items could be comple-
mented by additional items and psychometric properties
should be tested again. Otherwise, already existing lon-
ger scales assessing stigmatization might be an
alternative [33].
Recommendations for scale use
A broad range of reliability values of the survey’s scales was
found. Similarly, when investigating the unidimensional
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factorial structure of scales using CFA, a broad range of
model fits were found, suggesting evidence of a single
underlying factor in some but not all scales. According to
the results of this study, we distinguished several classes of
scales in terms of psychometric properties. The first class
showed very good reliability and at least mediocre model
fit, indicating that these scales provide sound results and
can be recommended for the application in further analyses
and surveys. This class includes scales of diabetes distress
(i.e. the PAID-5) and patient-provider-relationship in terms
of the patients’ assessment of care (i.e. the PACIC-DSF) in
the survey component for individuals with diabetes. The
perceived level of information scale administered in individ-
uals without diabetes may also be allocated to the first class,
based on its psychometric properties, but needs further ex-
ploration. Overall, the good reliability and the mean struc-
ture allow us to carefully recommend the PACIC-DSF to
be used for repeated measurements. Similarly, the IND [37]
may be used to monitor change in overall perceived levels
of information in case that future research efforts will pro-
duce a scale applicable to assess the overall level of infor-
mation as explained before. However, future research
should address the responsiveness of these scales.
For a second class of scales, results produced by the
application of these scales should be interpreted with
caution. Moreover, psychometric properties might need
to be further investigated in other samples and pretests
before including scales of this class into a survey. In in-
dividuals with diabetes, scales in this class include scales
for relative risk perception (i.e. optimistic bias), per-
ceived personal control, and depressive symptoms. In in-
dividuals without diabetes, scales in this class include
relative risk perception (i.e. optimistic bias).
For a third class of scales, items should probably not
be interpreted as a scale score but should rather be
interpreted as single items. Alternatively, scales should
be modified or extended by adding further items or
scales could be replaced by more reliable but possibly
longer already existing scales. For individuals with dia-
betes, this concerns self-efficacy, diabetes-related
stigmatization, and perceived level of information. For
individuals without diabetes this refers to perceived per-
sonal control, actual diabetes knowledge, and diabetes-
related stigmatization.
Strength and limitations
Strengths of the survey include that it was conducted on
a national level following a highly standardized survey
recruitment protocol and weighting procedures of the
RKI, allowing for the conclusions to be representative
for the German population. Another strength of the
present study is the use of Cronbach’s alpha in conjunc-
tion with CFA in order to evaluate the psychometrics
properties of the multiple item measures. Interpretation
of Cronbach’s alpha is more reasonable when the under-
lying structure of a scale is known, since Cronbach’s
alpha does not measure dimensionality [42, 60, 61].
Moreover, Cronbach’s alpha can be used to confirm uni-
dimensionality after the same has been suggested by fac-
torial analyses [61, 62].
Several limitations need to be considered. Extended
survey length represents a burden for participants and
possibly influences the quality of their answers [63].
Therefore, valid instruments often could not be included
in full length but only as subscales or single items. This
partly resulted in lower reliabilities, as seen in the
diabetes-related stigmatization scale in individuals with
and without diabetes and in single factor models with
only a few indicators. Because there were less than four
indicators per factor, unidimensionality could not be
tested for some scales. In other scales including only
four or five indicators per factor, model fit indices might
have been influenced by the small number of degrees of
freedom, resulting in higher rejection rates of the model.
Including several subscales belonging to the same instru-
ment in a factorial model might help to identify models
that fit the data adequately. Further, scales examined in
this study were assumed to be unidimensional and thus
tested by specifying models with a single latent factor.
However, models incorporating multiple factors or
underlying restrictions might be more suitable to fit the
data.
Beyond unidimensional solutions, future studies
should further investigate the possibility of multi-
dimensional solutions. For instance, for actual diabetes
knowledge, a three-factor-solution revealed better model
fit compared to the single-factor-solution with know-
ledge related to biological mechanisms of diabetes,
knowledge specific to type 2 diabetes, and knowledge
specific to type 1 diabetes were distinct subscales. For
the perceived personal control scale, alternative model
structures, e.g. including a method effect, were conceiv-
able as well, as this scale comprised two items phrased
positively and two items phrased negatively. Another al-
ternative model might comprise two factors with two in-
dicators each. Of those factors one might represent a
perceived controllability of risk of getting diabetes based
on one’s own efforts. The other one might represent the
perception of health or diabetes risks as uncontrollable
inescapable fate independent of one’s own efforts.
Hence, researchers using scales from this survey without
excellent fit indicating unidimensionality are recom-
mended to further explore the structure of these scales.
Conclusions
Taken together, a range of psychometric properties across
scales was found based on data of population-based survey
of diabetes-related knowledge and information needs for
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both people with and without known diabetes. Some
scales have shown adequate reliability and unidimension-
ality and are therefore recommended for future repeated
survey waves. Other scales should be used and interpreted
with caution, while a few scales should be reformulated or
used as single item measures. Findings of the survey might
serve to monitor diabetes-related factors at the population
level, to select valid instruments that allow for incorporat-
ing the patient perspective into health surveillance sys-
tems, and to provide future researchers the opportunity to
evaluate diabetes-specific scales among population-based
samples of adults with and without diabetes.
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